Medical Net Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Dai Hirakawa

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	8.3yrs
CEO sahipliği	9.8%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	7.3yrs

Son yönetim güncellemeleri

Recent updates

There's Been No Shortage Of Growth Recently For Medical Net's (TSE:3645) Returns On Capital

Aug 13

CEO

Dai Hirakawa (51 yo)

8.3yrs

Görev süresi

Mr. Dai Hirakawa has been Chief Executive Officer and Chairman of Medical Net, Inc. (formerly known as Medical Net Communications, Inc.) since August 2016 and serves as its Representative Director since Au...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Dai Hirakawa	Chairman & CEO	18.3yrs	Veri yok	9.76% ¥ 289.7m
Yuji Hirakawa	COO, President & Representative Director	23.4yrs	Veri yok	8.66% ¥ 257.0m
Ryusuke Hayakawa	Director	18.3yrs	Veri yok	6.58% ¥ 195.1m
Takahisa Ishii	Director	8.3yrs	Veri yok	0.56% ¥ 16.6m
Yasumasa Nakamura	Outside Auditor	17.3yrs	Veri yok	Veri yok
Hiroaki Kato	Independent Outside Director	5.3yrs	Veri yok	Veri yok
Soko Sugawara	Independent Outside Director	1.3yrs	Veri yok	Veri yok
Yuko Kuwata	Outside Auditor	1.3yrs	Veri yok	0.0044% ¥ 131.1k
Toshiharu Ko	Outside Auditor	6.3yrs	Veri yok	Veri yok
Keiichi Minowa	Full-Time Auditor	5.1yrs	Veri yok	Veri yok

7.3yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3645 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7.3 yıldır).

Medical Net Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Medical Net, Inc., Annual General Meeting, Aug 30, 2024

No independent directors

Medical Net, Inc., Annual General Meeting, Aug 29, 2022

No independent directors

Recent updates

Medical Net, Inc. (TSE:3645) announces an Equity Buyback for 400,000 shares, representing 4.42% for ¥100 million.

Medical Net, Inc. (TSE:3645) announces an Equity Buyback for 400,000 shares, representing 4.42% for ¥100 million.

First quarter 2025 earnings released: JP¥3.87 loss per share (vs JP¥2.32 profit in 1Q 2024)

New major risk - Financial data availability

Full year 2024 earnings released: EPS: JP¥0.55 (vs JP¥12.95 in FY 2023)

Medical Net, Inc. to Report Q1, 2025 Results on Oct 15, 2024

There's Been No Shortage Of Growth Recently For Medical Net's (TSE:3645) Returns On Capital

Medical Net, Inc., Annual General Meeting, Aug 30, 2024

Full year 2024 earnings released: EPS: JP¥0.55 (vs JP¥12.95 in FY 2023)

Medical Net, Inc. to Report Fiscal Year 2024 Results on Jul 12, 2024

Upcoming dividend of JP¥3.00 per share

Third quarter 2024 earnings released: JP¥7.63 loss per share (vs JP¥0.99 profit in 3Q 2023)

Medical Net, Inc. (TSE:3645) and NU-DENT Co., Ltd. completed the acquisition of Avision Co., Ltd from Achievable Co., Ltd., AMBS Co., Ltd., Siriporn Phipatpongpan, Suchai Yenruedee, Kanokporn Pattanichanon, Thitiphat Chunkampanart, Khanchai Phatanaphanchai and others.

Medical Net, Inc. (TSE:3645) and NU-DENT Co., Ltd. agreed to acquire Avision Co., Ltd from Achievable Co., Ltd., AMBS Co., Ltd., Siriporn Phipatpongpan, Suchai Yenruedee, Kanokporn Pattanichanon, Thitiphat Chunkampanart, Khanchai Phatanaphanchai and others for TBH80 million.

Medical Net, Inc. to Report Q3, 2024 Results on Apr 12, 2024

Second quarter 2024 earnings released: EPS: JP¥10.39 (vs JP¥8.17 in 2Q 2023)

Medical Net, Inc. to Report Q2, 2024 Results on Jan 12, 2024

First quarter 2024 earnings released: EPS: JP¥2.32 (vs JP¥6.47 in 1Q 2023)

Full year 2023 earnings released: EPS: JP¥12.95 (vs JP¥43.88 in FY 2022)

Medical Net, Inc. to Report Q1, 2024 Results on Oct 13, 2023

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: JP¥12.95 (vs JP¥43.88 in FY 2022)

Now 22% undervalued after recent price drop

Medical Net, Inc. to Report Fiscal Year 2023 Results on Jul 14, 2023

Upcoming dividend of JP¥2.50 per share at 0.6% yield

Third quarter 2023 earnings released: EPS: JP¥0.99 (vs JP¥9.76 in 3Q 2022)

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: JP¥8.17 (vs JP¥11.31 in 2Q 2022)

Medical Net, Inc. to Report Q2, 2023 Results on Jan 13, 2023

No independent directors

First quarter 2023 earnings released: EPS: JP¥6.47 (vs JP¥17.06 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥43.88 (vs JP¥15.28 in FY 2021)

Medical Net, Inc. to Report Q1, 2023 Results on Oct 14, 2022

Investor sentiment deteriorated over the past week

Medical Net, Inc., Annual General Meeting, Aug 29, 2022

Full year 2022 earnings released: EPS: JP¥43.88 (vs JP¥15.28 in FY 2021)

Now 21% undervalued

Now 22% undervalued

Medical Net, Inc. to Report Fiscal Year 2022 Results on Jul 13, 2022

Upcoming dividend of JP¥4.00 per share

No independent directors

Third quarter 2022 earnings released: EPS: JP¥9.76 (vs JP¥7.89 in 3Q 2021)

Investor sentiment improved over the past week

Medical Net, Inc. to Report Q3, 2022 Results on Apr 14, 2022

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS JP¥17.06 (vs JP¥3.59 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS JP¥30.56 (vs JP¥9.21 in FY 2020)

Upcoming dividend of JP¥8.00 per share

Third quarter 2021 earnings released: EPS JP¥15.79 (vs JP¥13.11 in 3Q 2020)

Investor sentiment improved over the past week

Medical Net, Inc. to Report Q3, 2021 Results on Apr 09, 2021

Second quarter 2021 earnings released: EPS JP¥8.51

Investor sentiment improved over the past week

Market pulls back on stock over the past week

New 90-day high: JP¥1,210

Market bids up stock over the past week

Medical Net, Inc. to Report Q1, 2021 Results on Oct 12, 2020

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş